Nuance Investments’s Quest Diagnostics DGX Stock Holding History

Nuance Investments’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.82M	Buy	27,470 +2,930	+12%	+$575K	0.99%	28
2026 Q1	$4.81M	Sell	24,540 -31,016	-56%	-$6.03M	0.67%	27
2025 Q4	$9.64M	Buy	55,556 +25,349	+84%	+$4.62M	1.06%	24
2025 Q3	$5.76M	Buy	+30,207	New	+$5.36M	0.59%	34
2024 Q2	–	Sell	-681,636	Closed	-$90.7M	–	53
2024 Q1	$90.7M	Buy	681,636 +79,152	+13%	+$10.3M	2.38%	14
2023 Q4	$83.1M	Buy	+602,484	New	+$79.2M	1.9%	19

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Nuance Investments's DGX Position: Q2 2026 in Review

Nuance Investments increased its Quest Diagnostics (DGX) stake by 12% in Q2 2026, buying an estimated $575K and bringing the position to 27,470 shares worth $5.82M. The position accounts for 0.99% of the portfolio, ranked #28.

Nuance Investments first reported a position in DGX in Q4 2023 and has held it in 6 quarters since. The position peaked at $90.7M in Q1 2024. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Nuance Investments held 27,470 shares of Quest Diagnostics worth $5.82M as of Q2 2026.
Nuance Investments bought 2,930 Quest Diagnostics shares in Q2 2026, an estimated $575K.
Quest Diagnostics made up 0.99% of Nuance Investments's portfolio in Q2 2026, its #28 holding.
Nuance Investments first reported a position in Quest Diagnostics in Q4 2023 and has held it in 6 quarters since.
Nuance Investments's Quest Diagnostics position peaked at $90.7M in Q1 2024.
1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Nuance Investments's 13F filing for Q2 2026, filed 7 Aug 2026.